Novo Nordisk's Ozempic wins FDA approval for chronic kidney disease

Health

Novo Nordisk's Ozempic Wins Fda Approval For Chronic Kidney Disease

By CNBC

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. The Food and Drug Administration on Tuesday approved Novo Nordisk 's Ozempic for patients with chronic kidney disease and diabetes, expanding the use of the ...Read more

Related Posts

How the Israel-Hamas ceasefire deal will unfold - and why it is so precarious

How the Israel-Hamas ceasefire deal will unfold - and why it is so precarious

Jan 23, 2025
Mouse With Two Male Parents Survives to Adulthood

Mouse With Two Male Parents Survives to Adulthood

Jan 28, 2025
Progress made on Los Angeles fires as evacuation orders lift

Progress made on Los Angeles fires as evacuation orders lift

Jan 24, 2025
Airstrike kills at least 70 seeking care at last functioning hospital in North Darfur capital as Sudan’s civil war rages

Airstrike kills at least 70 seeking care at last functioning hospital in North Darfur capital as Sudan’s civil war rages

Jan 26, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.